Financial Guidance Group’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Hold
20,000
0.09% 86
2026
Q1
$141K Sell
20,000
-1,945
-9% -$13.7K 0.06% 89
2025
Q4
$109K Hold
21,945
0.04% 89
2025
Q3
$99K Hold
21,945
0.04% 85
2025
Q2
$68.5K Hold
21,945
0.03% 84
2025
Q1
$55.1K Hold
21,945
0.03% 72
2024
Q4
$68K Hold
21,945
0.04% 72
2024
Q3
$52.2K Hold
21,945
0.03% 67
2024
Q2
$55.5K Buy
21,945
+10,000
+84% +$25.4K 0.03% 69
2024
Q1
$35.2K Hold
11,945
0.02% 57
2023
Q4
$36K Buy
11,945
+1,685
+16% +$5.42K 0.03% 53
2023
Q3
$38.9K Hold
10,260
0.03% 52
2023
Q2
$44.8K Hold
10,260
0.03% 52
2023
Q1
$29.4K Hold
10,260
0.02% 51
2022
Q4
$32.6K Hold
10,260
0.03% 50
2022
Q3
$60K Buy
+10,260
New +$90.5K 0.05% 49

Other funds holding DRTS

Financial Guidance Group's DRTS Position: Q2 2026 in Review

Financial Guidance Group held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 20,000 shares worth $252K. The position accounts for 0.09% of the portfolio, ranked #86.

Financial Guidance Group first reported a position in DRTS in Q3 2022 and has held it in 16 quarters since. 15 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Financial Guidance Group held 20,000 shares of Alpha Tau Medical worth $252K as of Q2 2026.
  • Financial Guidance Group left its Alpha Tau Medical share count unchanged in Q2 2026.
  • Alpha Tau Medical made up 0.09% of Financial Guidance Group's portfolio in Q2 2026, its #86 holding.
  • Financial Guidance Group first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 16 quarters since.
  • 15 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Financial Guidance Group's 13F filing for Q2 2026, filed 22 Jul 2026.